Asarfi Hospital Ltd — Important, 09-02-2026: Company Update

Asarfi Hospital Limited reported robust financial results for the quarter and nine months ended December 31, 2025. Revenue for the quarter rose 40% year-on-year to ₹46.06 Cr, with EBITDA at ₹10.12 Cr (22% margin) and PAT at ₹5.48 Cr (12% margin). This strong growth was driven by higher patient volumes, improved ARPOB, and a better case mix. The company saw operational momentum across its units, with specialty-led performance in high-acuity segments like Cardiology and Oncology. These results were reviewed by the Audit Committee and approved by the Board of Directors.